Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death

Journal of Nuclear Medicine

Volumn 42, Issue 12, 2001, Pages 1757-1767

  Wakabayashi, T ^a   Nakata, T ^a   Hashimoto, A ^a   Yuda, S ^a   Tsuchihashi, K ^a   Travin, M I ^a   Shimamoto, K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Nuclear medicine; Prognosis; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; SYMPATHETIC INNERVATION; TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035659304     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sympathetic stimulation and arrhythmias
2. Autonomic nervous system and sudden cardiac death
3. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure
4. 13I]iodobenzylguanidine
5. Abnormal 1-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy
6. Utility of -123 MIBG imaging and heart rate variability analysis as autonomic markers of sudden death
7. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by metaiodobenzylguanidine in patients with failing and non-failing hearts
8. Iodine-123 metaiodobenzyl-guanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic system disintegrity in patients with idiopathic dilated cardiomyopathy
9. Iodine123-metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants
10. Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload
11. A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure
12. 123-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy
13. Regional cardiac adrenergic function using 1-123 metaiodobenzylguanidine tomographic imaging after acute myocardial infarction
14. Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease
15. 123I] metaiodobenzylguanidine
16. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause
17. ACE inhibition reduced cardiac iodine-123-MIBG release in heart failure
18. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy
19. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function
20. Effect of uptake-1 inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine
21. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts: Implication for clinical studies
22. Cardiac sympathetic nerve function in congestive heart failure
23. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis
24. Regional cardiac adrenergic function using 1-123 metaiodobenzylguanidine tomographic imaging after myocardial infarction
25. Result of sympathetic denervation in the canine heart: Supersensitivity that may be arrhythmogenic
26. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content
27. Presynaptic modulation of efferent sympathetic and vagal neurotransmission in canine heart by hypoxia, high K+, low pH, and adenosine: Possible relevance to ischemia-induced denervation
28. Influence of age and gender on iodine-123 MIBG kinetics in normal lung
29. Timing of sudden death in patients with heart failure
30. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population
31. Circadian variation of total ischemic burden and its alteration with antianginal agents
32. Circadian variation and triggers of onset of cardiovascular disease
33. Impaired chronotropic response to exercise in patients with congestive heart failure
34. Impaired heart rate response to graded exercise: Prognostic implications of chronotropic incompetence in the Framingham Heart study
35. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
36. Successful launch of cardiac transplantation in Japan
37. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and norepinephrine as determinants of prognosis in heart failure
38. Randomized trial of low-dose amiodarone in severe congestive heart failure
39. Adverse consequence of high sympathetic nervous activity in the failing human heart
40. N-terminal proatrial natriuretic factor: An independent predictor of long-term prognosis after myocardial infarction